Ribosomal Protein S2 (RPS2) is a crucial component of the ribosome, the molecular machine responsible for protein synthesis in cells. In humans, ribosomes are composed of four ribosomal RNAs (rRNAs) and approximately 80 ribosomal proteins (RPs), including RPS2. The ribosome’s core composition is highly conserved across different species, reflecting its fundamental role in cellular life .
RPS2 is a part of the small 40S subunit of the ribosome. It plays a vital role in the assembly and stability of the ribosome, as well as in the translation of messenger RNA (mRNA) into proteins. The ribosome’s function is essential for maintaining cellular homeostasis and supporting various physiological processes .
While the ribosome’s core structure is largely invariant, recent studies have revealed some degree of variability in ribosomal components, including RPS2. This variability can be observed in the expression levels of ribosomal proteins across different tissues and cell types. For instance, certain ribosomal proteins exhibit tissue-specific expression patterns, which can influence the translation of specific mRNAs .
The expression of ribosomal proteins, including RPS2, can be dysregulated in various diseases, particularly cancer. Overexpression or mutations in ribosomal proteins have been linked to tumorigenesis and cancer progression. For example, RPS2 has been found to be overexpressed in malignant prostate cancer cell lines and tumor specimens, suggesting its potential role as a therapeutic target .
Human recombinant RPS2 is produced using recombinant DNA technology. This involves inserting the gene encoding RPS2 into a suitable expression system, such as bacteria or yeast, to produce the protein in large quantities. The recombinant protein is then purified for use in research and therapeutic applications. Recombinant RPS2 is valuable for studying ribosome function, protein synthesis, and the role of ribosomal proteins in disease .